Phosphorylation of nuclear MyoD is required for its rapid degradation

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 4994-4999

  Song, A N ^a,c   Wang, Q I ^a   Goebl, Mark G ^a   Harrington, Maureen A ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; MUTANT PROTEIN; MYOD PROTEIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS; SKELETAL MUSCLE; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0031810964     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.9.4994     Document Type: Article

References (51)

1. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
2. Banerjee, A., R. J. Deshaies, and V. Chau. 1995. Characterization of a dominant negative mutant of the cell cycle ubiquitin-conjugating enzyme Cdc34. J. Biol. Chem. 270:26209-26215.
3. Cobrinik, D. 1996. Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208:32-59.
4. Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287-301.
5. Crescenzi, M., T. P. Fleming, A. B. Lassar, H. Weintraub, and S. A. Aaronson. 1990. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA 87:8442-8446.
6. Davis, R. L., H. Weintraub, and A. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
7. Deshaies, R. J., V. Chau, and M. Kirschner. 1995. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J. 14:303-312.
8. Feldman, R. M. R., C. C. Correll, K. B. Kaplan, and R. J. Deshaies. 1997. A complex of Cdc4p, Skp1p, and Cdc53p/Cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91:221-230.
9. Goebl, M. G., L. Goetsch, and B. Byers. 1994. The Ubc3 (Cdc34) ubiquitin-conjugating enzyme is ubiquitinated and phosphorylated in vivo. Mol. Cell. Biol. 14:3022-3029.
10. Goebl, M. G., J. Yochem, S. Jentsch, J. P. McGrath, A. Varshavsky, and B. Byers. 1988. The yeast cell cycle gene CDC34 encodes a ubiquitin-conjugating enzyme. Science 241:1331-1335.
11. Goldberg, A. L. 1995. Functions of the proteasome: the lysis at the end of the tunnel. Science 268:522-523.
12. Gonen, H., I. Stancovski, D. Shkedy, T. Hadari, B. Bercovich, E. Bengal, S. Mesilat, O. Abu-Hatoum, A. L. Schwartz, and A. Ciechanover. 1996. Isolation, characterization, and partial purification of a novel ubiquitin-protein ligase, E3. J. Biol. Chem. 271:302-310.
13. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
14. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
15. Harrington, M. A., B. Konicek, A. Song, X. L. Xia, W. J. Fredericks, and F. J. Rauscher III. 1993. Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem. 268:21271-21275.
16. Henchoz, S., Y. Chi, B. Catarin, I. Herskowitz, R. J. Deshaies, and M. Peter. 1997. Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast. Genes Dev. 11:3046-3060.
17. Hochstrasser, M. 1995. Ubiquitin, proteasomes, and the regulation of intra-cellular protein degradation. Curr. Opin. Cell Biol. 7:215-223.
18. Horwitz, M. 1996. Hypermethylated myoblasts specifically deficient in MyoD autoactivation as a consequence of instability of MyoD. Exp. Cell Res. 226:170-182.
19. Jones, K. A. 1997. Taking a new TAK on Tat transactivation. Genes Dev. 11:2593-2599.
20. Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331-342.
21. Kornitzer, D., B. Raboy, R. G. Kulka, and G. R. Fink. 1994. Regulated degradation of the transcription factor Gen4. EMBO J. 13:6021-6030.
22. Lanker, S., M. H. Valdivieso, and C. Wittenberg. 1996. Rapid degradation of the G1 cyclin Cln2 induced by CDK-dependent phosphorylation. Science 271:1597-1601.
23. Lassar, A. B., J. N. Buskin, D. Lockshon, S. Apone, S. D. Hauschka, and H. Weintraub. 1989. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase promoter. Cell 58:823-831.
24. Li, F. N., and M. Johnston. 1997. Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J. 16:5629-5638.
25. Lin, W.-C., and S. Desiderio. 1993. Regulation of V(D)J recombination activator protein RAG-2 by phosphorylation. Science 260:953-959.
26. SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17:368-383.
27. Ludolph, D. C., and S. F. Konieczny. 1995. Transcription factor families: muscling in on the myogenic program. FASEB J. 9:1595-1604.
28. Madden, S. L., D. M. Cook, J. F. Morris, A. Gashler, V. P. Sukhatme, and F. J. Rauscher III. 1991. Transcriptional repression mediated by the WT1 Wilm's tumor gene product. Science 253:1550-1553.
29. Megeney, L. A., B. Kablar, K. Garrett, J. E. Anderson, and M. A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10:1173-1183.
30. Moreno, S., and P. Nurse. 1990. Substrates for p34cdc2: in vivo veritas? Cell 61:549-551.
31. Morisaki, H., A. Fujimoto, A. Ando, Y. Nagata, K. Ikeda, and M. Nakanishi. 1997. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase inhibitor by cyclin E/CDK2. Biochem. Biophys. Res. Commun. 240:386-390.
32. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Dell Sal, V. Chau, P. R. Yew, G. R. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
33. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
34. Plon, S. E., K. A. Leppig, H.-N. Do, and M. Groudine. 1993. Cloning of the human homolog of the CDC34 cell cycle gene by complementation in yeast. Proc. Natl. Acad. Sci. USA 90:10484-10488.
35. Rao, S. S., C. Chu, and D. S. Kohtz. 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259-5267.
36. Rudnicki, M. A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390.
37. Rudnicki, M. A., P. N. J. Schnegelsberg, R. H. Stead, T. Braun, H.-H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
38. Sambrook, J. E., F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
39. Seemüller, E., A. Lupas, D. Stock, J. Löwe, R. Huber, and W. Baumeister. 1995. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 268:579-582.
40. Segel, I. H. 1976. p376. Biochemical calculations, 2nd ed. John Wiley & Sons, New York, N.Y.
41. Kip1. Genes Dev. 11:1464-1478.
42. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024.
43. Skowyra, D., K. L. Craig, M. Tyers, S. J. Elledge, and J. W. Harper. 1997. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91:209-219.
44. Slansky, J. E., and P. J. Farnham. 1996. Introduction to the E2F family: protein structure and gene regulation. Curr. Top. Microbiol. Immunol. 208: 1-31.
45. Sorrentino, V., R. Pepperkok, R. L. Davis, W. Ansorge, and L. Philipson. 1990. Cell proliferation inhibited by MyoD independently of myogenic differentiation. Nature (London) 345:813-815.
46. Thayer, M. J., S. J. Tapscott, R. L. Davis, W. E. Wright, A. B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD. Cell 58:241-248.
47. Thorburn, A. M., P. A. Walton, and J. R. Feramisco. 1993. MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mot. Biol. Cell 4:705-713.
48. Venuti, J. M., and P. Cserjesi. 1996. Molecular embryology of skeletal myogenesis. Curr. Top. Dev. Biol. 34:169-206.
49. Kip1. EMBO J. 16:5334-5344.
50. Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T. K. Blackwell, D. Turner, S. Hollenberg, Y. Zbuang, and A. Lassar. 1991. The MyoD family: nodal point during specification of the muscle cell lineage. Science 251:761-766.
51. Willems, A. R., S. Lanker, E. E. Patton, K. L. Craig, T. F. Nason, N. Mathias, R. Kobayashi, C. Wittenberg, and M. Tyers. 1996. Cdc53 targets phosphorylated G1 cyclins for degradation by the ubiquitin proteolytic pathway. Cell 62:453-463.